(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:150221

Synonyms

alpha-D-gluco-hexopyranosyl-(1->6)-alpha-D-gluco-hexopyranosyl-(1->6)-alpha-D-gluco-hexofuranose
Glc(a1-6)Glc(a1-6)a-Glcf

Definition

References

glygen:G35061TT
glytoucan:G35061TT

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype affecting (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-hydroxy-2-[(2R,3R,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]ethoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model